People who eat little or no animal food, including some vegans and strict vegetarians, may be more likely to have low intake unless they use fortified foods or supplements
Each vial is sterile, hypotonic, nonpyrogenic, and can be used for intramuscular, intravenous, and subcutaneous administration
Persistent symptoms or no measurable change after a full cycle is a sign to reassess
Proposed Mechanism BPC-157 appears to work through multiple pathways: Maintaining vesicular integrity (affecting VMATs and dopamine transporters) Possibly occupying its own vesicular storage sites Competing for dopamine receptor binding Functionally substituting when dopaminergic neurons are lost This last property, essentially filling in for missing dopamine function, would explain why the peptide counteracts both receptor agonists (apomorphine) and antagonists (haloperidol, fluphenazine, clozapine, sulpiride) with equal effectiveness